Skip to content

Clinical trials

Phase 2 Liver Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Phase: Phase 2 Country / region: United States Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20021
20041
20054
20062
20074
20081
20092
20102
20122
20133
20141
20155
20163
20172
20182
20192
20201
20215
20223
20233
20245
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated10
Recruiting6
Active, not recruiting3
Unknown status2
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)5
Gilead Sciences4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
Mirum Pharmaceuticals, Inc.3
Genfit2
Ocera Therapeutics2
Sagimet Biosciences Inc.2
Yale University2
89bio, Inc.1
Akcea Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases61
Non-alcoholic Fatty Liver Disease17
Fibrosis13
Hepatitis C10
Digestive System Diseases9
Fatty Liver9
Hepatitis7
Virus Diseases5
Hepatitis C, Chronic4
Hepatitis, Chronic4

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.